NurExone Biologic Inc. (TSXV:NRX)
Canada · Delayed Price · Currency is CAD 0.6900
+0.0300 (4.55%)
At close: Feb 27, 2026
NurExone Biologic Market Cap
NurExone Biologic has a market cap or net worth of CAD 62.62 million as of March 2, 2026. Its market cap has increased by 45.63% in one year.
Market Cap
62.62M
Enterprise Value
61.36M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.69
Market Cap Chart
Since June 23, 2022, NurExone Biologic's market cap has increased from 33.48M to 62.62M, an increase of 87.01%. That is a compound annual growth rate of 18.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 62.62M | 4.63% |
| Dec 31, 2025 | 59.85M | 36.16% |
| Dec 31, 2024 | 43.95M | 208.80% |
| Dec 28, 2023 | 14.23M | -14.84% |
| Dec 22, 2022 | 16.71M | -50.08% |
| Jun 23, 2022 | 33.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ME Therapeutics Holdings | 75.12M |
| Medicenna Therapeutics | 75.08M |
| Sharp Therapeutics | 67.67M |
| MedMira | 48.82M |
| Sernova Biotherapeutics | 47.47M |
| Devonian Health Group | 38.03M |
| BriaCell Therapeutics | 37.78M |
| Defence Therapeutics | 35.00M |